help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andersson, S.
Right arrow Articles by Russel, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andersson, S.
Right arrow Articles by Russel, D. W.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 130-136, Copyright © 1996 by Endocrine Society

ARTICLES

Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency

S Andersson, WM Geissler, L Wu, DL Davis, MM Grumbach, MI New, HP Schwarz, SL Blethen, BB Mendonca, W Bloise, SF Witchel, GB Cutler Jr, JE Griffin, JD Wilson and DW Russel
Department of Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065, USA.

Autosomal recessive mutations in the 17 beta-hydroxysteroid dehydrogenase 3 gene impair the formation of testosterone in the fetal testis and give rise to genetic males with female external genitalia. Such individuals are usually raised as females, but virilize at the time of expected puberty as the result of increases in serum testosterone. Here we describe mutations in 12 additional subjects/families with this disorder. The 14 mutations characterized to date include 10 missense mutations, 3 splice junction abnormalities, and 1 small deletion that results in a frame shift. Three of these mutations have occurred in more than 1 family. Complementary DNAs incorporating 9 of the 10 missense mutations have been constructed and expressed in reporter cells; 8 of the 9 missense mutations cause almost complete loss of enzymatic activity. In 2 subjects with loss of function, missense mutations testosterone levels in testicular venous blood were very low. Considered together, these findings strongly suggest that the common mechanism for testosterone formation in postpubertal subjects with this disorder is the conversion of circulating androstenedione to testosterone by one or more of the unaffected 17 beta-hydroxysteroid dehydrogenase isoenzymes.


This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
J. M Day, H. J Tutill, A. Purohit, and M. J Reed
Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
Endocr. Relat. Cancer, September 1, 2008; 15(3): 665 - 692.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. T. T. Thai, M. Kalbasi, K. Lagerstedt, L. Frisen, I. Kockum, and A. Nordenskjold
The Valine Allele of the V89L Polymorphism in the 5-{alpha}-Reductase Gene Confers a Reduced Risk for Hypospadias
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6695 - 6698.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. K. Agarwal and R. J. Auchus
Minireview: Cellular Redox State Regulates Hydroxysteroid Dehydrogenase Activity and Intracellular Hormone Potency
Endocrinology, June 1, 2005; 146(6): 2531 - 2538.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
A. H. Payne and D. B. Hales
Overview of Steroidogenic Enzymes in the Pathway from Cholesterol to Active Steroid Hormones
Endocr. Rev., December 1, 2004; 25(6): 947 - 970.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. L. Britt, P. G. Stanton, M. Misso, E. R. Simpson, and J. K. Findlay
The Effects of Estrogen on the Expression of Genes Underlying the Differentiation of Somatic Cells in the Murine Gonad
Endocrinology, August 1, 2004; 145(8): 3950 - 3960.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. N. Kalantaridou and G. P. Chrousos
Monogenic Disorders of Puberty
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2481 - 2494.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
M. S. Mahendroo, K. M. Cala, D. L. Hess, and D. W. Russell
Unexpected Virilization in Male Mice Lacking Steroid 5{alpha}-Reductase Enzymes
Endocrinology, November 1, 2001; 142(11): 4652 - 4662.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. K. Gupta, D. H. Geller, and R. J. Auchus
Pitfalls in Characterizing P450c17 Mutations Associated with Isolated 17,20-Lyase Deficiency
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4416 - 4423.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Lindqvist, I. A. Hughes, and S. Andersson
Substitution Mutation C268Y Causes 17{beta}-Hydroxysteroid Dehydrogenase 3 Deficiency
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 921 - 923.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
P. J. O'Shaughnessy, P. J. Baker, M. Heikkila, S. Vainio, and A. P. McMahon
Localization of 17{beta}-Hydroxysteroid Dehydrogenase/17-Ketosteroid Reductase Isoform Expression in the Developing Mouse Testis--Androstenedione Is the Major Androgen Secreted by Fetal/Neonatal Leydig Cells
Endocrinology, July 1, 2000; 141(7): 2631 - 2637.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
17{beta}-Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo Mutations
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4713 - 4721.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
J. D. Wilson
The Role of Androgens in Male Gender Role Behavior
Endocr. Rev., October 1, 1999; 20(5): 726 - 737.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
C. H. Tsai-Morris, A. Khanum, P.-Z. Tang, and M. L. Dufau
The Rat 17{beta}-Hydroxysteroid Dehydrogenase Type III: Molecular Cloning and Gonadotropin Regulation
Endocrinology, August 1, 1999; 140(8): 3534 - 3542.
[Abstract] [Full Text]

Home page
 NEJMHome page
E. Y. Adashi and J. D. Hennebold
Single-Gene Mutations Resulting in Reproductive Dysfunction in Women
N. Engl. J. Med., March 4, 1999; 340(9): 709 - 718.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Zeitoun, K. Takayama, H. Sasano, T. Suzuki, N. Moghrabi, S. Andersson, A. Johns, L. Meng, M. Putman, B. Carr, et al.
Deficient 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17{beta}-Estradiol
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4474 - 4480.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Moghrabi, I. A. Hughes, A. Dunaif, and S. Andersson
Deleterious Missense Mutations and Silent Polymorphism in the Human 17{beta}-Hydroxysteroid Dehydrogenase 3 Gene (HSD17B3)
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2855 - 2860.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
J. W. M. Martens, M. Verhoef-Post, N. Abelin, M. Ezabella, S. P. A. Toledo, H. G. Brunner, and A. P. N. Themmen
A Homozygous Mutation in the Luteinizing Hormone Receptor Causes Partial Leydig Cell Hypoplasia: Correlation between Receptor Activity and Phenotype
Mol. Endocrinol., June 1, 1998; 12(6): 775 - 784.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. V. J. Mustonen, V. V. Isomaa, T. Vaskivuo, J. Tapanainen, M. H. Poutanen, F. Stenbäck, R. K. Vihko, and P. T. Vihko
Human 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Messenger Ribonucleic Acid Expression and Localization in Term Placenta and in Endometrium during the Menstrual Cycle
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1319 - 1324.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Can, Y.-S. Zhu, L.-Q. Cai, Q. Ling, M. D. Katz, S. Akgun, C. H. L. Shackleton, and J. Imperato-McGinley
The Identification of 5{alpha}-Reductase-2 and 17{beta}-Hydroxysteroid Dehydrogenase-3 Gene Defects in Male Pseudohermaphrodites from a Turkish Kindred
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 560 - 569.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
T. M. Penning
Molecular Endocrinology of Hydroxysteroid Dehydrogenases
Endocr. Rev., June 1, 1997; 18(3): 281 - 305.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society